Skip to main content

Venrock — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

156
Companies
$8.0B
Total invested
$54.9M
Avg. check
51
Industries
Health Care 11Biotechnology 9Artificial Intelligence (AI) 5Software 5Medical 4Therapeutics 4+45 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 156
Suki
October 2026

Suki develops artificial intelligence solutions to assist clinicians with clinical documentation and administrative tasks.

Artificial Intelligence (AI) · Redwood City$90.0M Series E
Carbon Recycle Technologies
October 2026

Carbon Recycle Technologies is a renewable energy company producing bio-methanol and green hydrogen.

Biomass Energy · Singapore$279K Grant
KymaThera
October 2026

KymaThera is an biotech startup that develops precision small-molecule drugs targeting diseases like cancer and fibrosis.

Biopharma · San Diego$80.0M Series B
Encoded Therapeutics
September 2026

Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.

Biotechnology · South San Francisco$275.0M Series F
Aligned Marketplace
August 2026

Aligned Marketplace connects self-insured employers with independent advanced primary and specialty care providers.

Health Care · New York$20.0M Series A
Expedition Therapeutics
August 2026

Expedition Therapeutics develops treatments for COPD and other inflammatory respiratory diseases.

Biotechnology · San Francisco$115.0M Series B
Arca Wealth
June 2026

Arca Wealth is a wealth management firm that combines human advisors with AI to deliver personalized financial advice

Financial Services · New York$48.5M Series A
Element Biosciences
June 2026

Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.

Biotechnology · San DiegoSeries E
Jade Biosciences
June 2026

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Biopharma · Waltham$150.0M Post-IPO Equity
cAMPfield Therapeutics
May 2026

cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.

Biopharma · San Diego$180.0M Series A
Moment
May 2026

Moment develops AI software for investment management and wealth management operations.

Analytics · New York$78.0M Series C
GenLogs
May 2026

GenLogs is a freight intelligence company that offers truck carrier mapping services via AI-driven roadside sensors.

Artificial Intelligence (AI) · ArlingtonCorporate Round
Pharvaris
May 2026

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

Biotechnology · Zug$132.3M Post-IPO Equity
Coherus Biosciences
February 2026

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Biotechnology · Redwood City$50.1M Post-IPO Equity
Porter
January 2026

Easiest way to deploy on AWS/GCP/Azure

Information Technology · New YorkSeries A
FINNY
December 2025

FINNY is an AI-powered prospecting and marketing platform that helps financial advisors identify and connect with potential clients.

Artificial Intelligence (AI) · New York$17.0M Series A
Aledade
December 2025

Aledade is a primary care center.

Health Care · Bethesda$500.0M Debt Financing
Archetype AI
November 2025

Archetype AI develops Physical AI agents that harness real-world sensor data to enhance decision-making and automate processes.

Artificial Intelligence (AI) · Palo Alto$35.0M Series A
Biohaven Pharmaceutical
November 2025

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

Biotechnology · New Haven$200.0M Post-IPO Equity
Syllo
October 2025

Syllo is a legal technology platform

Artificial Intelligence (AI) · Brooklyn$30.0M Venture - Series Unknown
Skyryse
October 2025

Skyryse is a manufacturing firm that offers aerospace hardware and software operating systems and components design, production, and sales.

Aerospace · El Segundo$167.1M Series C
Averto Medical
October 2025

Averto Medical is a medical device manufacturing company.

Health Care · Belmont$2.1M Grant
KalVista Pharmaceuticals
September 2025

KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).

Biotechnology · Cambridge$125.0M Post Ipo Debt
Euclid Power
September 2025

Euclid Power delivers software that streamlines renewable energy project development with integrated tools and expertise.

Energy Management · New York$20.0M Series A

Where Venrock invests

Health Care11
Biotechnology9
Artificial Intelligence (AI)5
Software5
Medical4
Therapeutics4

About Venrock's portfolio

How many companies has Venrock invested in?▸

Venrock has invested in 156 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Venrock invest in?▸

Venrock's top investment sectors include Health Care, Biotechnology, Artificial Intelligence (AI), Software, Medical. The firm invests across 51 different industry categories.

What is Venrock's largest investment?▸

Among tracked funding rounds, Aledade received $500.0M in a Debt Financing round. Venrock's total known invested capital is $8.0B.

What is the average investment size for Venrock?▸

Venrock's average investment size is $54.9M across its portfolio of 156 companies.

What are Venrock's most recent investments?▸

Recent Venrock portfolio additions include Suki, Carbon Recycle Technologies, KymaThera, Encoded Therapeutics, Aligned Marketplace. These companies were founded in 2020 or later.

Reach the founders behind these 156 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →